<DOC>
	<DOCNO>NCT02825264</DOCNO>
	<brief_summary>STARflo novel suprachoroidal Glaucoma Drainage Device ( GDD ) , bleb-free , exhibit anti-fibrotic property . Release CE Marked implant limit lead Glaucoma Centers Europe . Therefore Clinical Experience Program initiate expand surgical clinical practice knowledge use STARflo reduce intraocular pression ( IOP ) patient suffer open angle glaucoma real world population patient . This program design international multicenter observational study Patient data may collect retrospectively and/or prospectively 5 year surgery . The aim program document patient 's benefit follow implantation STARflo implant real-word patient population , learn surgical practice collect data support future cost-effectiveness analysis</brief_summary>
	<brief_title>STAR-LIFE Registry</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Inclusion criterion : Patients suffer open angle glaucoma case narrow angle glaucoma implant STARflo implant 2011 Patients sign Data Release form Exclusion criterion : Patients sign Data Release form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Glaucoma Drainage Device</keyword>
	<keyword>STARflo</keyword>
</DOC>